These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21998477)

  • 1. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.
    Black S; Nicolay U; Vesikari T; Knuf M; Del Giudice G; Della Cioppa G; Tsai T; Clemens R; Rappuoli R
    Pediatr Infect Dis J; 2011 Dec; 30(12):1081-5. PubMed ID: 21983214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
    Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
    Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.
    Gilbert PB; Fong Y; Juraska M; Carpp LN; Monto AS; Martin ET; Petrie JG
    BMC Infect Dis; 2019 May; 19(1):453. PubMed ID: 31117986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
    N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections.
    Lim WW; Feng S; Wong SS; Sullivan SG; Cowling BJ
    J Infect Dis; 2024 Jul; 230(1):152-160. PubMed ID: 39052734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ; Campbell JD; Zangwill KM; Rowe T; Wolff M
    N Engl J Med; 2006 Mar; 354(13):1343-51. PubMed ID: 16571878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
    J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.
    Torii Y; Kimura H; Ochi N; Kaneko K; Ando H; Kiuchi T; Ito Y
    Vaccine; 2011 Jun; 29(25):4187-9. PubMed ID: 21513762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to the influenza vaccine in healthcare workers.
    Sacadura-Leite E; Sousa-Uva A; Rebelo-de-Andrade H
    Vaccine; 2012 Jan; 30(2):436-41. PubMed ID: 22064268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.
    Machado AA; Machado CM; Boas LS; Lopes MC; Gouvêa Ade F; Succi RC; Mendoza TR; Kanashiro TM; Machado DM
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):999-1003. PubMed ID: 21284525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.